Schmitz, A. K., Sorg, R. V., Stoffels, G., Grauer, O. M., Galldiks, N., Steiger, H., . . . Rapp, M. (2021). Diagnostic impact of additional O-(2-[18F]fluoroethyl)-L-tyrosine ( 18 F-FET) PET following immunotherapy with dendritic cell vaccination in glioblastoma patients. London [u.a.]: Taylor & Francis.
Chicago Style CitationSchmitz, Ann Kristin, et al. Diagnostic Impact of Additional O-(2-[18F]fluoroethyl)-L-tyrosine ( 18 F-FET) PET Following Immunotherapy With Dendritic Cell Vaccination in Glioblastoma Patients. London [u.a.]: Taylor & Francis, 2021.
MLA CitationSchmitz, Ann Kristin, et al. Diagnostic Impact of Additional O-(2-[18F]fluoroethyl)-L-tyrosine ( 18 F-FET) PET Following Immunotherapy With Dendritic Cell Vaccination in Glioblastoma Patients. London [u.a.]: Taylor & Francis, 2021.